Logo
x

Search

Subscribe Now

Gastric Cancer

Unlocking Approval: Moitreyee Chatterjee-Kishore from Astellas & Kohei Shitara in Conversation with PharmaShots

Unlocking Approval: Moitreyee Chatterjee-Kishore from Astellas & Kohei Shitara in Conversation with PharmaShots

  • June 24, 2024
Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Cancer

Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...

  • February 2, 2022
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China

Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China

  • August 17, 2020
Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastric Cancer

Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastr...

  • May 27, 2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Orphan Drug Designation for Gastric Cancer

Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Orphan Drug Designation for Gastri...

  • May 22, 2020
Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer

Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer

  • January 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.